Company: CERO
Filing Date: 2025-05-27
Form Type: POS AM
Source: 0001213900-25-047469
Chunk: 254

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-27
Form: POS AM
Chunk 254
---
iv) shares                 
 underlying 215,740 Pre-Funded Warrants held by Mr. Atwood and GVN, LLC, which is the maximum number of such Pre-Funded Warrants held thereby 
 that may be exercised without exceeding the beneficial ownership limitations set forth therein. Excludes warrants and/or pre-funded          
 warrants held by Mr. Atwood and GVN, LLC (of which Mr. Atwood and Lynne H. Edminster serve as managers, and the sole member is the           
 Trust) that are in excess of the applicable beneficial ownership limitations.                                                                |

| (6) | Consists of 9,024 shares of Common Stock issuable pursuant to 
 stock options exercisable within 60 days of May 19, 2025.     |

| (7) | Consists of (i) 59 shares of Common Stock held by Kathleen LaPorte,                                                                  
 (ii) 9,660 shares of Common Stock, held by the Kathleen LaPorte Revocable Trust, of which Ms. LaPorte serves as a trustee, and (iii) 
 9,024 shares of Common Stock issuable pursuant to stock options exercisable within 60 days of May 19, 2025.                          |

| (8) | Consists of 9,024 shares of Common Stock issuable pursuant to 
 stock options exercisable within 60 days of May 19, 2025.     |

| (9) | Consists of 7,529 shares of Common Stock issuable pursuant to 
 stock options exercisable within 60 days of May 19, 2025.     |

146 SELLING SECURITYHOLDER This prospectus relates to the possible resale from time to time by the Selling Securityholder of any or all of the Common Stock that may be issued by us to the Selling Securityholder under the Keystone Purchase Agreements.

| ● | up to 2,100,000 shares of our                                                                                           
 Common Stock that have been or may be issued by us to Keystone pursuant to the Keystone Purchase Agreements, including: |

| o | 2,086,357 Keystone Purchase 
 Shares; and                 |

| o | 13,643 Keystone Commitment 
 Shares.                    |

As used in this prospectus, the term “ Selling Securityholder” includes Keystone, and its permitted pledgees, donees, transferees, assignees, successors, designees, successors-in-interest and others who later come to hold any of Keystone’s interest in the shares of Common